Drug middlemen are duking it out to buy their customers. Most Americans pick up their prescription drugs at the local ...

The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.

We recently compiled a list of 10 Best Stocks To Buy Right Now According To Billionaire Cliff Asness. In this article, we ...

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Deutsche Bank analyst George Hill maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $579.00.

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target ...

McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2025 financial results after market close on Wednesday, November 6, 2024. The company will host a live webcast of the earnings ...

The company will have access to McKesson’s differentiated Oncology platform, including oncology care products and services. “This is a historic moment for FCS and reflects the evolution of our ...

The global healthcare electronic data interchange (EDI) market was valued at approximately USD 4.83 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.6% from 2024 ...

Cardinal Health on Friday agreed to acquire community cancer center operator Integrated Oncology Network for $1.12 billion in ...

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

McKesson Corporation MCK is well-poised for growth in the coming quarters, courtesy of its strong Biologics business. The optimism led by a decent first-quarter fiscal 2025 performance and improving ...